UPDATE: Argus Downgrades Teva Pharma (TEVA) to Hold Citing Concerns over Opioid Payout
Tweet Send to a Friend
(Updated - January 27, 2022 7:17 AM EST)
Argus analyst Jasper Hellweg downgraded Teva Pharma (NYSE: TEVA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Argus analyst Jasper Hellweg downgraded Teva Pharma (NYSE: TEVA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
